Experimental lovastatin myopathy

Andrew J. Waclawik, Sigurd Lindal, Andrew G Engel

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Lovastatin (LS) is a potent HMG-CoA inhibitor used in the treatment of hypercholesterolemia. In humans it can cause a severe, necrotizing myopathy with myoglobinuria and renal failure. To investigate the pathogenesis of LS-induced myopathy we studied the effects of LS on rat skeletal muscle. Lewis rats were gavage-fed 1 mg/g body weight/day of LS. Control rats received carboxymethylcellulose-based suspension by gavage. Gastrocnemius and soleus, fast and slow twitch muscles respectively, were studied by light and electron microscopy. By day 10 LS-treated rats became severely weak. Gastrocnemius was severely affected with degeneration of membranous organelles and microvacuole formation, but soleus was spared. Eventually, 20-50% of the gastrocnemius but none of the soleus fibers became necrotic. Non-necrotic fibers showed no increases of acid phosphatase, indicating that autophagy was not excited. We conclude that LS causes muscle injury by inducing degeneration of membranous organelles, and fast twitch muscle fibers are selectively vulnerable to LS myopathy.

Original languageEnglish (US)
Pages (from-to)542-549
Number of pages8
JournalJournal of Neuropathology and Experimental Neurology
Volume52
Issue number5
StatePublished - Sep 1993

Fingerprint

Lovastatin
Muscular Diseases
Organelles
Myoglobinuria
Fast-Twitch Muscle Fibers
Muscles
Carboxymethylcellulose Sodium
Autophagy
Acid Phosphatase
Hypercholesterolemia
Renal Insufficiency
Suspensions
Electron Microscopy
Skeletal Muscle
Body Weight
Light
Wounds and Injuries

Keywords

  • HMG-CoA reductase inhibitors
  • Hypercholesterolemia
  • Lovastatin
  • Myopathy

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neuroscience(all)

Cite this

Experimental lovastatin myopathy. / Waclawik, Andrew J.; Lindal, Sigurd; Engel, Andrew G.

In: Journal of Neuropathology and Experimental Neurology, Vol. 52, No. 5, 09.1993, p. 542-549.

Research output: Contribution to journalArticle

Waclawik, AJ, Lindal, S & Engel, AG 1993, 'Experimental lovastatin myopathy', Journal of Neuropathology and Experimental Neurology, vol. 52, no. 5, pp. 542-549.
Waclawik, Andrew J. ; Lindal, Sigurd ; Engel, Andrew G. / Experimental lovastatin myopathy. In: Journal of Neuropathology and Experimental Neurology. 1993 ; Vol. 52, No. 5. pp. 542-549.
@article{7b4cf3ad86fc47bb9ac68bbce6ddd929,
title = "Experimental lovastatin myopathy",
abstract = "Lovastatin (LS) is a potent HMG-CoA inhibitor used in the treatment of hypercholesterolemia. In humans it can cause a severe, necrotizing myopathy with myoglobinuria and renal failure. To investigate the pathogenesis of LS-induced myopathy we studied the effects of LS on rat skeletal muscle. Lewis rats were gavage-fed 1 mg/g body weight/day of LS. Control rats received carboxymethylcellulose-based suspension by gavage. Gastrocnemius and soleus, fast and slow twitch muscles respectively, were studied by light and electron microscopy. By day 10 LS-treated rats became severely weak. Gastrocnemius was severely affected with degeneration of membranous organelles and microvacuole formation, but soleus was spared. Eventually, 20-50{\%} of the gastrocnemius but none of the soleus fibers became necrotic. Non-necrotic fibers showed no increases of acid phosphatase, indicating that autophagy was not excited. We conclude that LS causes muscle injury by inducing degeneration of membranous organelles, and fast twitch muscle fibers are selectively vulnerable to LS myopathy.",
keywords = "HMG-CoA reductase inhibitors, Hypercholesterolemia, Lovastatin, Myopathy",
author = "Waclawik, {Andrew J.} and Sigurd Lindal and Engel, {Andrew G}",
year = "1993",
month = "9",
language = "English (US)",
volume = "52",
pages = "542--549",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Experimental lovastatin myopathy

AU - Waclawik, Andrew J.

AU - Lindal, Sigurd

AU - Engel, Andrew G

PY - 1993/9

Y1 - 1993/9

N2 - Lovastatin (LS) is a potent HMG-CoA inhibitor used in the treatment of hypercholesterolemia. In humans it can cause a severe, necrotizing myopathy with myoglobinuria and renal failure. To investigate the pathogenesis of LS-induced myopathy we studied the effects of LS on rat skeletal muscle. Lewis rats were gavage-fed 1 mg/g body weight/day of LS. Control rats received carboxymethylcellulose-based suspension by gavage. Gastrocnemius and soleus, fast and slow twitch muscles respectively, were studied by light and electron microscopy. By day 10 LS-treated rats became severely weak. Gastrocnemius was severely affected with degeneration of membranous organelles and microvacuole formation, but soleus was spared. Eventually, 20-50% of the gastrocnemius but none of the soleus fibers became necrotic. Non-necrotic fibers showed no increases of acid phosphatase, indicating that autophagy was not excited. We conclude that LS causes muscle injury by inducing degeneration of membranous organelles, and fast twitch muscle fibers are selectively vulnerable to LS myopathy.

AB - Lovastatin (LS) is a potent HMG-CoA inhibitor used in the treatment of hypercholesterolemia. In humans it can cause a severe, necrotizing myopathy with myoglobinuria and renal failure. To investigate the pathogenesis of LS-induced myopathy we studied the effects of LS on rat skeletal muscle. Lewis rats were gavage-fed 1 mg/g body weight/day of LS. Control rats received carboxymethylcellulose-based suspension by gavage. Gastrocnemius and soleus, fast and slow twitch muscles respectively, were studied by light and electron microscopy. By day 10 LS-treated rats became severely weak. Gastrocnemius was severely affected with degeneration of membranous organelles and microvacuole formation, but soleus was spared. Eventually, 20-50% of the gastrocnemius but none of the soleus fibers became necrotic. Non-necrotic fibers showed no increases of acid phosphatase, indicating that autophagy was not excited. We conclude that LS causes muscle injury by inducing degeneration of membranous organelles, and fast twitch muscle fibers are selectively vulnerable to LS myopathy.

KW - HMG-CoA reductase inhibitors

KW - Hypercholesterolemia

KW - Lovastatin

KW - Myopathy

UR - http://www.scopus.com/inward/record.url?scp=0027281868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027281868&partnerID=8YFLogxK

M3 - Article

C2 - 8360706

AN - SCOPUS:0027281868

VL - 52

SP - 542

EP - 549

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 5

ER -